# Phase I Pilot Study of Total-Body Irradiation, Anti-Thymocyte Globulin and Cyclophosphamide Followed By Syngeneic or Autologous Peripheral Blood Stem Cell Transplantation in Patients With Multiple Sclerosis

> **NCT00014755** · PHASE1 · COMPLETED · sponsor: **Fred Hutchinson Cancer Center** · enrollment: 35 (—)

## Conditions studied

- Multiple Sclerosis

## Interventions

- **DRUG:** anti-thymocyte globulin
- **DRUG:** cyclophosphamide
- **DRUG:** filgrastim
- **DRUG:** prednisone
- **PROCEDURE:** peripheral blood stem cell transplantation
- **PROCEDURE:** irradiation

## Key facts

- **NCT ID:** NCT00014755
- **Lead sponsor:** Fred Hutchinson Cancer Center
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 1997-12
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** 35 (—)
- **Last updated:** 2005-06-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00014755

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00014755, "Phase I Pilot Study of Total-Body Irradiation, Anti-Thymocyte Globulin and Cyclophosphamide Followed By Syngeneic or Autologous Peripheral Blood Stem Cell Transplantation in Patients With Multiple Sclerosis". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT00014755. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*